Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
BMC Struct Biol ; 19(1): 6, 2019 03 27.
Artigo em Inglês | MEDLINE | ID: mdl-30917807

RESUMO

BACKGROUND: Plasmodium vivax merozoite surface protein 3α (PvMSP3α) is a promising vaccine candidate which has shown strong association with immunogenicity and protectiveness. Its use is however complicated by evolutionary plasticity features which enhance immune evasion. Low complexity regions (LCRs) provide plasticity in surface proteins of Plasmodium species, but its implication in vaccine design remain unexplored. Here population genetic, comparative phylogenetic and structural biology analysis was performed on the gene encoding PvMSP3α. RESULTS: Three LCRs were found in PvMSP3α block II. Both the predicted tertiary structure of the protein and the phylogenetic trees based on this region were influenced by the presence of the LCRs. The LCRs were mainly B cell epitopes within or adjacent. In addition a repeat motif mimicking one of the B cell epitopes was found within the PvMSP3a block II low complexity region. This particular B cell epitope also featured rampant alanine substitutions which might impair antibody binding. CONCLUSION: The findings indicate that PvMSP3α block II possesses LCRs which might confer a strong phenotypic plasticity. The phenomenon of phenotypic plasticity and implication of LCRs in malaria immunology in general and vaccine candidate genes in particular merits further exploration.


Assuntos
Antígenos de Protozoários/química , Antígenos de Protozoários/imunologia , Malária Vivax/imunologia , Plasmodium vivax/isolamento & purificação , Proteínas de Protozoários/química , Proteínas de Protozoários/imunologia , Substituição de Aminoácidos , Antígenos de Protozoários/genética , Epitopos de Linfócito B/metabolismo , Etiópia , Humanos , Evasão da Resposta Imune , Malária Vivax/parasitologia , Modelos Moleculares , Filogenia , Plasmodium vivax/imunologia , Plasmodium vivax/metabolismo , Polimorfismo Genético , Domínios Proteicos , Estrutura Terciária de Proteína , Proteínas de Protozoários/genética
2.
Sci Rep ; 13(1): 20788, 2023 11 27.
Artigo em Inglês | MEDLINE | ID: mdl-38012191

RESUMO

Ethiopia has the greatest burden of Plasmodium vivax in Africa, but little is known about the epidemiological landscape of parasites across the country. We analysed the genomic diversity of 137 P. vivax isolates collected nine Ethiopian districts from 2012 to 2016. Signatures of selection were detected by cross-country comparisons with isolates from Thailand (n = 104) and Indonesia (n = 111), representing regions with low and high chloroquine resistance respectively. 26% (35/137) of Ethiopian infections were polyclonal, and 48.5% (17/35) of these comprised highly related clones (within-host identity-by-descent > 25%), indicating frequent co-transmission and superinfection. Parasite gene flow between districts could not be explained entirely by geographic distance, with economic and cultural factors hypothesised to have an impact on connectivity. Amplification of the duffy binding protein gene (pvdbp1) was prevalent across all districts (16-75%). Cross-population haplotype homozygosity revealed positive selection in a region proximal to the putative chloroquine resistance transporter gene (pvcrt-o). An S25P variant in amino acid transporter 1 (pvaat1), whose homologue has recently been implicated in P. falciparum chloroquine resistance evolution, was prevalent in Ethiopia (96%) but not Thailand or Indonesia (35-53%). The genomic architecture in Ethiopia highlights circulating variants of potential public health concern in an endemic setting with evidence of stable transmission.


Assuntos
Antimaláricos , Malária Falciparum , Malária Vivax , Humanos , Plasmodium vivax , Malária Vivax/parasitologia , Etiópia/epidemiologia , Cloroquina/farmacologia , Cloroquina/uso terapêutico , Malária Falciparum/parasitologia , Genômica , Proteínas de Protozoários/genética , Proteínas de Protozoários/metabolismo , Antimaláricos/farmacologia , Antimaláricos/uso terapêutico , Resistência a Medicamentos/genética , Plasmodium falciparum/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA